Literature DB >> 17420929

IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.

Fuencisla Matesanz, Alfredo Caro-Maldonado, Maria Fedetz, Oscar Fernández, Roger L Milne, Miguel Guerrero, Concepción Delgado, Antonio Alcina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17420929     DOI： 10.1007/s00415-006-0416-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  17 in total

1.  Evidence for pathogenic heterogeneity in multiple sclerosis.

Authors:  Claudia F Lucchinetti; Wolfgang Bruck; Hans Lassmann
Journal:  Ann Neurol       Date:  2004-08       Impact factor: 10.422

2.  Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region.

Authors:  M Sarfarazi; A Child; D Stoilova; G Brice; T Desai; O C Trifan; D Poinoosawmy; R P Crick
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

Review 3.  The epidemiology of multiple sclerosis.

Authors:  W E Hogancamp; M Rodriguez; B G Weinshenker
Journal:  Mayo Clin Proc       Date:  1997-09       Impact factor: 7.616

4.  Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11.

Authors:  P Reed; F Cucca; S Jenkins; M Merriman; A Wilson; P McKinney; E Bosi; G Joner; K S Rønningen; K Rønningen; E Thorsby; D Undlien; T Merriman; A Barnett; S Bain; J Todd
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

5.  Allelic expression and interleukin-2 polymorphisms in multiple sclerosis.

Authors:  F Matesanz; M Fedetz; M Collado-Romero; O Fernández; M Guerrero; C Delgado; A Alcina
Journal:  J Neuroimmunol       Date:  2001-09-03       Impact factor: 3.478

6.  The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements.

Authors:  H P Kim; J Kelly; W J Leonard
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

7.  Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor.

Authors:  N Sharfe; H K Dadi; M Shahar; C M Roifman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

8.  DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.

Authors:  O Fernández; V Fernández; A Alonso; A Caballero; G Luque; M Bravo; A León; C Mayorga; L Leyva; E de Ramón
Journal:  J Neurol       Date:  2004-04       Impact factor: 4.849

Review 9.  Genetics of multiple sclerosis: linkage and association studies.

Authors:  Mara Giordano; Sandra D'Alfonso; Patricia Momigliano-Richiardi
Journal:  Am J Pharmacogenomics       Date:  2002

10.  Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.

Authors:  Mandy J McGeachy; Leigh A Stephens; Stephen M Anderton
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422
View more
  21 in total

1.  Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis.

Authors:  Marie-Claude Babron; Hervé Perdry; Adam E Handel; Sreeram V Ramagopalan; Vincent Damotte; Bertrand Fontaine; Bertram Müller-Myhsok; George C Ebers; Françoise Clerget-Darpoux
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

2.  Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk.

Authors:  María L Cavanillas; Antonio Alcina; Concepción Núñez; Virginia de las Heras; Miguel Fernández-Arquero; Manuel Bartolomé; Emilio G de la Concha; Oscar Fernández; Rafael Arroyo; Fuencisla Matesanz; Elena Urcelay
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

Review 3.  Pharmacogenetics: potential role in the treatment of diabetes and obesity.

Authors:  Adrian Vella; Michael Camilleri
Journal:  Expert Opin Pharmacother       Date:  2008-05       Impact factor: 3.889

4.  Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.

Authors:  Claire Dandine-Roulland; Hervé Perdry
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

5.  Genetics of experimental allergic encephalomyelitis supports the role of T helper cells in multiple sclerosis pathogenesis.

Authors:  Elizabeth P Blankenhorn; Russell Butterfield; Laure K Case; Emma H Wall; Roxana del Rio; Sean A Diehl; Dimitry N Krementsov; Naresha Saligrama; Cory Teuscher
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

6.  Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis.

Authors:  Antonio Alcina; Oscar Fernández; Juan Ramón Gonzalez; Antonio Catalá-Rabasa; María Fedetz; Dorothy Ndagire; Laura Leyva; Miguel Guerrero; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; Fuencisla Matesanz
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

7.  Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.

Authors:  Antonio Alcina; Sreeram V Ramagopalan; Oscar Fernández; Antonio Catalá-Rabasa; María Fedetz; Dorothy Ndagire; Laura Leyva; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; George C Ebers; Fuencisla Matesanz
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

8.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Authors:  Oscar Fernández; Alfredo R-Antigüedad; María Jesús Pinto-Medel; Mari Mar Mendibe; Nestor Acosta; Begoña Oliver; Miguel Guerrero; Marcos Papais-Alvarenga; Victoria Fernández-Sánchez; Laura Leyva
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

9.  IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).

Authors:  Antonio Alcina; María Fedetz; Dorothy Ndagire; Oscar Fernández; Laura Leyva; Miguel Guerrero; María M Abad-Grau; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; Fuencisla Matesanz
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

10.  IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.

Authors:  Lisa M Maier; Christopher E Lowe; Jason Cooper; Kate Downes; David E Anderson; Christopher Severson; Pamela M Clark; Brian Healy; Neil Walker; Cristin Aubin; Jorge R Oksenberg; Stephen L Hauser; Alistair Compston; Stephen Sawcer; Philip L De Jager; Linda S Wicker; John A Todd; David A Hafler
Journal:  PLoS Genet       Date:  2009-01-02       Impact factor: 5.917
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.